Search

You searched for "tear"

2443 results found

Verteporfin shortage: treatment options and outcomes in chronic non-resolving central serous chorioretinopathy

4 February 2025 | | EYE - Vitreo-Retinal
Half-dose photodynamic therapy (HD-PDT) with verteporfin has been the therapy of choice in non-resolving central serous chorioretinopathy lasting longer than four months. Since 2021, a worldwide shortage of verteporfin due to manufacturing issues prompted adjustments in treatment practices. This retrospective,...
Ophthalmologica journal cover image.

Vascular density evaluated by SS-OCTA and microperimetry in RP

4 August 2025 | | EYE - Vitreo-Retinal
The aim of this retrospective, observational cross-sectional one-year study was to evaluate the retinal and choroidal vessel density in the macular area with swept-source optical coherence tomography angiography (SS-OCTA) in patients of retinitis pigmentosa (RP), to compare this data with...

Sight Sciences OMNI® Masterclass, Colchester

23 January 2023 | Awards, Conferences & Anniversaries
Saturday 14th January saw Sight Sciences hold their third UK Masterclass for the OMNI Surgical System.

Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.

22 May 2023 | Research & Development, Awards, Conferences & Anniversaries
This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.

Haag-Streit Academy celebrates 10 years of first class clinical CPD-accredited training

26 March 2024 | Company Profiles, Recruitment & Personnel, Research & Development
Haag-Streit UK is pleased to celebrate 10 years of providing high quality slit lamp, biometry and perimetry training. In 2014, the Haag-Streit Academy was born, with the launch of the first ‘Improving Outcomes’ biometry course.

Vabysmo receives NICE approval

27 September 2024 | Awards, Conferences & Anniversaries, Company Profiles, Research & Development
The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...

Haag-Streit UK relaunches the Perkins Mk 3 hand-held applanation tonometer

10 December 2024 | Company Profiles, Research & Development
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce that they have relaunched the Perkins Mk 3 hand-held applanation tonometer. Haag-Streit UK discontinued the...

HASA OPTIX Certifies as a B Corporation

18 December 2024 | Company Profiles
Premium recyclable ophthalmic instrument company HASA OPTIX announces its certification as a B Corporation (B Corp) company. In a press release, the Brussels-based scale-up confirmed its score of 109.7 points on the B Impact Assessment, in which nonprofit B Lab...

RayOne EMV honoured with King’s Award for Enterprise

8 May 2025 | Awards, Conferences & Anniversaries
Rayner, the UK’s sole manufacturer of intraocular lenses (IOLs) and a global leader in cataract surgery solutions, has received the prestigious King’s Award for Enterprise 2025 in the Innovation category for its groundbreaking RayOne EMV lens. Launched in 2020 and...

RANZCO Congress 2025

14 November 2025 -17 November 2025
The Royal Australian and New Zealand College of Ophthalmologists Annual Congress 2025

Optic nerve swelling – your survival guide (part 1)

1 August 2017 | | EYE - Neuro-ophthalmology
Assessment of optic nerve appearance and functions is a daily routine in neuro-ophthalmology. Following a recent high profile court case there has been a significant increase in the amount of referral to ophthalmology departments to assess the optic nerve and...

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

1 December 2016 | | EYE - Vitreo-Retinal
Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...